Hormonal Contraceptives Market Size, Share & Industry Analysis, By Product (Pills, Injectable, Vaginal Rings, Intrauterine Devices, Implants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel, Public Channel & NGOs, and Others) and Regional Forecast, 2019-2026

Pune, India -- (SBWire) -- 03/03/2020 --Hormonal Contraceptives Market Size to Reach 26.6 USD billion, Rising Prevalence of Sexually Transmitted Diseases to Help Market Gain Impetus, says Fortune Business Insights. The global hormonal contraceptives market is projected to reach a value of USD 26.6 billion by 2026, with a notable CAGR of 5.8% during the forecast period 2019 to 2026. This is owing to the unmet needs for contraceptives worldwide, especially in developing nations. The market was valued at USD 16.7 billion in 2018.

The World Health Organization estimated a rise in the utilization of modern contraceptives from 54% in 1990 to about 57.4% in 2015. This is attributable to the easy availability and user reliability of contraceptive products all over the world. Such factors are likely to add impetus to the hormonal contraceptives market size in the forecast duration.
Get Sample - Hormonal Contraceptives Market Report

Fortune Business Insights™ presents a comprehensive overview of the hormonal birth-control market in their recently published study titled, "Hormonal Contraceptives Market Size, Share & Industry Analysis, By Product (Pills, Injectable, Vaginal Rings, Intrauterine Devices, Implants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel, Public Channel & NGOs, and Others) and Regional Forecast, 2019-2026."

Highlights of the Report:

The report on the hormonal birth-control market offers the following:

An extensive overview of the market
Details of the fertility statistics
Key industry insights and significant business achievements so far
Factors promoting, demoting, threatening, and providing opportunities to the market
List of segments and names of the leading ones
Significant players and their key strategies
Other hormonal contraceptive market trends
Cost-efficiency and Easy Availability of Contraceptive Products to Promote Market Growth
The increasing cases of sexually transmitted diseases such as HIV/AIDS is a prime factor promoting the hormonal contraceptives market growth. Besides this, the cost efficiency and easy availability of contraceptives products such as pills, is also helping the market gain traction. Moreover, the fact that contraceptives are a better and reliable way of controlling unwanted pregnancy as compared to diaphragms/sponges or condoms is also expected to help increase the overall hormonal contraceptive market size in the forecast period. Furthermore, the advent of new user-friendly and cost-efficient products into the market, such as contraceptive implants, vaginal rings, and injectable, are likely to help increase the overall hormonal birth control market revenue in the coming years.

Increasing incidences of Unwanted Pregnancies Among Teenagers – Reason behind North America's Dominance

From a geographical perspective, the global hormonal birth control market is widespread in Latin America, North America, Asia Pacific, North America, and Europe. Among these, North America accounted for the largest hormonal contraceptives market share with a revenue generation of US$ 5.8 Bn in 2018. This is attributed to the presence of major manufacturing companies coupled with the rise in awareness about different birth-control methods in the U.S. Besides this, the rising incidences of unwanted pregnancies among teenagers are also anticipated to help North America earn a promising hormonal contraceptive market share in the forecast duration as well.

Companies Offering Range of Contraceptive Products to Intensify Market Competition

Current hormonal birth control market manufacturers are focusing on the launch of new and user-friendly products to gain a competitive edge in the overall market. For this, players are investing huge sums into research and development of novel contraceptive products. Currently, Merck & Co, is dominating the market on account of two of their supernova products, namely Nexplanon/Implanon and Nuvaring. Following Merck & Co. is Bayer AG, which is famous for its range of intrauterine devices apart from the range of contraceptive pills. As per a lead analyst at Fortune Business Insights™, the range of products from Mirena, consisting of 3 intrauterine devices, earned a revenue of USD 1,143 million in the year 2018.

Key Industry Developments of the Hormonal Birth-control Market Consists of:

December 17, 2019 – The launch of the ethinyl/etonogestrel estradiol vaginal ring called NuvaRing ® was announced by Prasco in partnership with Merck & Co. Inc. This ring is small in size and is in the shape of a flexible ring used for preventing pregnancy.

Direct Purchase This Report

Significant Players of the Hormonal Contraceptives Market Include:

Piramal Enterprises Ltd
Novartis AG
Teva Pharmaceutical Industries
Janssen Pharmaceuticals, Inc.
Allergan
Merck & Co., Inc.
Pfizer, Inc.
Mylan N.V.

Table of content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Recent industry developments such as mergers & acquisitions
regulatory scenario for key countries
Fertility Statistics for Key Countries, 2018
Reimbursement Scenario
New Product Launches
Global Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Product
Pills
Injectable
Vaginal Ring
Intrauterine Device
Implants
Others
Market Analysis, Insights and Forecast – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
Market Analysis, Insights and Forecast – By Country
North America
Europe
Asia pacific
Latin America
Middle East & Africa
North America Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis – By Product
Pills
Injectable
Vaginal Ring
Intrauterine Device
Implants
Others
Market Analysis – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
Market Analysis – By Country
S.
Canada
Europe Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis – By Product
Pills
Injectable
Vaginal Ring
Intrauterine Device
Implants
Others
Market Analysis – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
Market Analysis – By Country
K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia pacific Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis – By Product
Pills
Injectable
Vaginal Ring
Intrauterine Device
Implants
Others
Market Analysis – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
Market Analysis – By Country
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis – By Product
Pills
Injectable
Vaginal Ring
Intrauterine Device
Implants
Others
Market Analysis – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
Market Analysis – By Country/Sub-region
Brazil
Mexico
Rest of Latin America
Middle East & Africa Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis – By Product
Pills
Injectable
Vaginal Ring
Intrauterine Device
Implants
Others
Market Analysis – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Public Channel & NGOs
Others
Market Analysis – By Country
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Analysis
Key Industry Developments
Global Market Share Analysis (2018)
Competition Dashboard
Comparative Analysis – Major Players
Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
Allergan
Merck & Co., Inc.
Janssen Pharmaceuticals, Inc.
Teva Pharmaceutical Industries
Pfizer, Inc.
Piramal Enterprises Ltd
Mylan N. V.
Novartis AG
Strategic Recommendations

Get more detailed Analysis Of Hormonal Contraceptives Market Report

About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com